These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
535 related articles for article (PubMed ID: 34705343)
1. Microenvironment-Responsive Prodrug-Induced Pyroptosis Boosts Cancer Immunotherapy. Xiao Y; Zhang T; Ma X; Yang QC; Yang LL; Yang SC; Liang M; Xu Z; Sun ZJ Adv Sci (Weinh); 2021 Dec; 8(24):e2101840. PubMed ID: 34705343 [TBL] [Abstract][Full Text] [Related]
2. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma. Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654 [TBL] [Abstract][Full Text] [Related]
3. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy. Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764 [TBL] [Abstract][Full Text] [Related]
4. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy. Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775 [TBL] [Abstract][Full Text] [Related]
5. RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy. Hao Y; Chen Y; He X; Han R; Yang C; Liu T; Yang Y; Liu Q; Qian Z Biomaterials; 2023 Feb; 293():121975. PubMed ID: 36580720 [TBL] [Abstract][Full Text] [Related]
6. A dual-pathway pyroptosis inducer based on Au-Cu Yan X; Chen C; Ren Y; Su T; Chen H; Yu D; Huang Y; Chao M; Wu G; Jiang G; Gao F Acta Biomater; 2024 Oct; 188():329-343. PubMed ID: 39278301 [TBL] [Abstract][Full Text] [Related]
7. A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer. Yao D; Wang Y; Bian K; Zhang B; Wang D Biomaterials; 2023 Jan; 292():121920. PubMed ID: 36442436 [TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum-targeted iridium(III) photosensitizer induces pyroptosis for augmented tumor immunotherapy. Zhi YS; Chen T; Liang BF; Jiang S; Yao DH; He ZD; Li CY; He L; Pan ZY J Inorg Biochem; 2024 Nov; 260():112695. PubMed ID: 39153452 [TBL] [Abstract][Full Text] [Related]
9. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy. Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771 [TBL] [Abstract][Full Text] [Related]
10. Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy. Luo C; Sun B; Wang C; Zhang X; Chen Y; Chen Q; Yu H; Zhao H; Sun M; Li Z; Zhang H; Kan Q; Wang Y; He Z; Sun J J Control Release; 2019 May; 302():79-89. PubMed ID: 30946853 [TBL] [Abstract][Full Text] [Related]
11. Diselenide-Based Dual-Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer Immunotherapy. Wan SC; Ye MJ; Yang QC; Zhang T; Zhang MJ; Ma XB; Xu JM; Wang S; Wu ZZ; Yang LL; Shen XM; Xu Z; Sun ZJ Adv Healthc Mater; 2023 Mar; 12(7):e2202135. PubMed ID: 36479643 [TBL] [Abstract][Full Text] [Related]
12. In situ formed reactive oxygen species-responsive dipyridamole prodrug hydrogel: Spatiotemporal drug delivery for chemoimmunotherapy. Xiao B; Shi X; Xu X; Liu J; Pan Y; Xu H; Sun W; Slater NKH; Patra HK; Gao J; Shen Y; Tang J J Control Release; 2024 Nov; 375():454-466. PubMed ID: 39216598 [TBL] [Abstract][Full Text] [Related]
13. Dual-Activated Nano-Prodrug for Chemo-Photodynamic Combination Therapy of Breast Cancer. Lu Z; Xu G; Yang X; Liu S; Sun Y; Chen L; Liu Q; Liu J Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555298 [TBL] [Abstract][Full Text] [Related]
14. A Triple-Responsive Polymeric Prodrug Nanoplatform with Extracellular ROS Consumption and Intracellular H Li Y; Cao Y; Ma K; Ma R; Zhang M; Guo Y; Song H; Sun N; Zhang Z; Yang W Adv Healthc Mater; 2024 Jun; 13(16):e2303568. PubMed ID: 38319010 [TBL] [Abstract][Full Text] [Related]
15. Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy. Yang J; Lv Q; Wei W; Yang Z; Dong J; Zhang R; Kan Q; He Z; Xu Y Drug Deliv; 2018 Nov; 25(1):807-814. PubMed ID: 29553858 [TBL] [Abstract][Full Text] [Related]
16. Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy. Zhang S; Wang Z; Kong Z; Wang Y; Zhang X; Sun B; Zhang H; Kan Q; He Z; Luo C; Sun J Theranostics; 2021; 11(12):6019-6032. PubMed ID: 33897896 [TBL] [Abstract][Full Text] [Related]
17. Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer. Wang Y; Chen Y; Ji DK; Huang Y; Huang W; Dong X; Yao D; Wang D J Nanobiotechnology; 2024 Aug; 22(1):461. PubMed ID: 39090622 [TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory-Photodynamic Nanostimulators for Invoking Pyroptosis to Augment Tumor Immunotherapy. Qiu W; Su W; Xu J; Liang M; Ma X; Xue P; Kang Y; Sun ZJ; Xu Z Adv Healthc Mater; 2022 Nov; 11(21):e2201233. PubMed ID: 36049144 [TBL] [Abstract][Full Text] [Related]
19. Mitochondria-targeted polyprodrug nanoparticles induce mitochondrial stress for immunogenic chemo-photodynamic therapy of ovarian cancer. Zhang W; Chen G; Chen Z; Yang X; Zhang B; Wang S; Li Z; Yang Y; Wu Y; Liu Z; Yu Z J Control Release; 2024 Jul; 371():470-483. PubMed ID: 38849094 [TBL] [Abstract][Full Text] [Related]
20. Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer. Li L; Tian H; Zhang Z; Ding N; He K; Lu S; Liu R; Wu P; Wang Y; He B; Luo M; Peng P; Yang M; Nice EC; Huang C; Xie N; Wang D; Gao W ACS Appl Mater Interfaces; 2023 Jan; 15(1):452-468. PubMed ID: 36538368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]